In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Azuma T.   Ichikawa D.   Nambu H.   Iguchi T.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

By Meunier J.-C.  

European Journal of Pharmacology, Vol. 340, Iss. 1, 1997-12 ,pp. : 1-15

Elsevier

Access to resources Recommend Favorite

Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice

By Kamei J.   Ohsawa M.   Kashiwazaki T.   Nagase H.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice

By Gavioli E.   Vaughan C.   Marzola G.   Guerrini R.   Mitchell V.   Zucchini S.   Lima T.   Rae G.   Salvadori S.   Regoli D.   Calo’ G.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 796-811

Bentham Science Publishers

Access to resources Recommend Favorite